U.S. Electrical Stock News

Enterprise Products Partners has delivered a 146.4% total return over the past five years, yet the latest valuation checks send a more measured signal about how much upside might still be left in the current price of US$38.12. A 146.4% return over five years points to a stock that has already rewarded patient holders, which raises the bar for any new valuation upside. Future cash flow resilience from its midstream infrastructure can support current pricing, while any sustained pressure on...

In July 2026, Celcuity announced that its drug REVTORPYK (gedatolisib) received FDA approval and NCCN Category 1 preferred guideline status for use with fulvestrant, with or without palbociclib, in adults with HR+/HER2- locally advanced or metastatic breast cancer without a PIK3CA mutation after progression on endocrine therapy. A key differentiator is that REVTORPYK is the only FDA-approved therapy targeting all class I PI3K isoforms and both mTORC1 and mTORC2 complexes, supported by...

Netflix (NasdaqGS:NFLX) has secured global streaming rights to The Walking Dead Universe in a multi-year licensing deal with AMC Global Media. The agreement covers the core series and six spin offs, with availability in markets such as the UK, Italy, Australia, and New Zealand starting in 2027. The deal is described as one of the largest recent streaming content agreements, with co exclusive rights across international territories. Netflix is a global streaming company that relies on a deep...

In late July 2026, United Parcel Service (UPS) announced a suite of digital shipping enhancements for small and mid-sized businesses, including a real-time pickup management dashboard, streamlined online label creation, and a refreshed mobile app integrated with The UPS Store network. These upgrades, including Smart Pickup tools that can cut pickup costs by as much as half and RFID-enabled labels for near-real-time tracking, highlight UPS’s push to deepen relationships with smaller shippers...

In late July 2026, Linde held its annual general meeting, declared a US$1.60 per-share quarterly dividend, and reported that shareholders rejected a proposal requesting a report on its renewable electricity procurement strategy. At the same time, Linde expanded its low-carbon footprint by signing six new renewable power purchase agreements across Europe, Africa, and India, supporting its existing mix where around half of its global electricity use already comes from low-carbon sources. We’ll...

Range Resources Corporation recently reported its second-quarter 2026 results, with revenue of US$833.57 million and net income of US$195.32 million, alongside an update that it repurchased 2,000,000 shares for US$78.35 million, completing a total buyback of 35,915,000 shares under its 2019 authorization. While quarterly revenue and earnings were lower than a year earlier, the company’s stronger first-half results and completion of a multi-year buyback program highlight how capital returns...

In July 2026, AbCellera Biologics announced a collaboration with Vertex Pharmaceuticals to research, develop, manufacture, and commercialize multispecific T-cell engagers for autoimmune diseases and other conditions, with Vertex funding all R&D and retaining commercialization rights while AbCellera receives US$28 million upfront plus potential milestones and royalties. This alliance adds an immunology-focused antibody platform to Vertex’s existing genetic medicine strengths, potentially...

ASML Holding (NasdaqGS:ASML) is back in focus after its recent share price moves, with the stock closing at US$1,651.44. Investors are weighing this performance against the company’s current size and profitability. See our latest analysis for ASML Holding. Recent trading has been choppy for ASML Holding, with the 1 day share price return of 6.5% coming after a 7 day share price decline of 8.4% and a 30 day share price decline of 17.0%. At the same time, the 1 year total shareholder return of...

Baidu’s Apollo Go and Freenow by Lyft began testing the sixth-generation RT6 autonomous vehicles in London’s Brent borough, after Apollo Go secured Hong Kong’s first fully driverless Level 4 public-road trial permit on Airport Island in July 2026. These trials extend Apollo Go’s right-hand-drive experience from Hong Kong to the UK, underscoring the platform’s ability to operate across diverse regulatory and road systems. We’ll now explore how Apollo Go’s London and Hong Kong rollouts...

Solstice Advanced Materials stock has given investors a sharp correction in the past month, yet the current market-multiple view still leans on the expensive side and the broader valuation checks only offer a mixed verdict rather than a clear bargain. The share price is down 35.2% over the past month, which pressures confidence in how much investors are willing to pay for the stock right now. The planned acquisition of Element Solutions may support expectations for a larger advanced...

KBR (NYSE:KBR) has named its planned independent Mission Technology Solutions spin-off "Trinzic." The company also announced executive designations for Trinzic as part of the separation process. This move marks a further step toward formally separating the Mission Technology Solutions business from KBR. KBR operates across government services and technology-focused engineering, with Mission Technology Solutions playing a central role in its defense and intelligence-facing work. The formal...

Brookdale Senior Living (BKD) has drawn fresh attention after its stock closed at $14.62, with recent returns mixed over the past week, month, and past 3 months, and a sharp gain over the past year. See our latest analysis for Brookdale Senior Living. Despite a recent 30 day share price return that is down 9.14%, Brookdale Senior Living still has strong momentum when viewed over a longer horizon, with a 1 year total shareholder return of 88.65% and a 3 year total shareholder return of very...

SELLAS Life Sciences Group (SLS) is back in focus as investors watch for the final analysis of its Phase 3 REGAL trial in acute myeloid leukemia, with the pivotal readout reportedly close. See our latest analysis for SELLAS Life Sciences Group. At a share price of $10.29, SELLAS Life Sciences Group has seen a very large 1 year total shareholder return. The 90 day share price return of 108.72% contrasts with a 30 day share price decline of 30.28%, suggesting momentum has cooled as investors...

In recent months, CAVA Group reported that it has been expanding its restaurant base rapidly, averaging 18.7% annual new-unit growth over the past two years, while also delivering 9.8% year-on-year same-store sales growth that points to rising demand at existing locations. This combination of fast footprint expansion and strong same-restaurant performance sets CAVA apart from much slower-growing peers in the broader restaurant sector, suggesting its Mediterranean concept is resonating across...

Rithm Capital (NYSE:RITM) is weighing a potential shift from its current real estate investment trust structure to a traditional C corporation, according to recent management commentary. The company is also working to expand its third party asset management platform and grow fee based revenue streams. Rithm Capital enters this decision point with shares recently trading around $9.87. The stock is up 9.9% over the past week and 5.1% over the past month, while returns year to date and over...

Hercules Capital stock is coming off a solid 5 year return, yet current checks suggest the market price may still sit below what its fundamentals imply. At the last close of US$15.94, both the intrinsic value estimate from the Excess Returns model and the earnings multiple view point to a market that may be underpricing the company. Hercules Capital has returned 60.3% over the past 5 years, which puts recent short term weakness into a longer term context of gains. Future lending growth and...

ImmunityBio recently reported that the Emirates Drug Establishment granted Marketing Authorization in the UAE for ANKTIVA across BCG-unresponsive non-muscle invasive bladder cancer and metastatic non-small cell lung cancer, expanding the drug’s regulatory reach to 34 countries with its broadest label yet. This is the first worldwide approval to cover the full spectrum of BCG-unresponsive bladder disease, including both carcinoma in situ and papillary-only tumors, while also adding a...

Lumen Technologies (LUMN) is back in focus as investors look ahead to its second quarter 2026 earnings report on August 4, with attention on its multiyear transformation and recent connectivity and security product moves. See our latest analysis for Lumen Technologies. Lumen Technologies’ recent 1-day share price return of 5.13% and 7-day share price return of 0.46% sit against a 30-day share price decline of 14.58% and a 90-day share price decline of 29.61%, while the 1-year total...

Exponent, Inc. has reported past second-quarter 2026 results showing sales of US$148.86 million and revenue of US$171.61 million, with net income rising to US$29.4 million and earnings per share reaching US$0.60, alongside an expanded buyback program totaling US$836.7 million since inception. Alongside stronger earnings driven in part by AI-related consulting demand, Exponent’s increased buybacks and ongoing dividends highlight management’s emphasis on returning capital while supporting its...

Coherent Corp. is set to report its fourth-quarter fiscal 2026 results on August 12, with analysts highlighting its positive Earnings ESP and history of outperforming consensus estimates. At the same time, weaker guidance from peer Corning has cast a cloud over the broader optical and AI data-center supply chain that Coherent helps serve. Next, we’ll examine how anticipation of Coherent’s earnings amid mixed AI optics sentiment could influence its existing investment narrative. Explore 26...

Yum! Brands (YUM) has released its second quarter 2026 earnings, reporting higher sales, revenue, and net income compared with a year earlier. The stock’s movement now reflects how investors interpret these results. See our latest analysis for Yum! Brands. The latest earnings release appears to be the key driver of Yum! Brands’ recent momentum, with a 1-day share price return of 3.34% and a 7-day share price return of 6.53% lifting the stock to US$157. Over a longer stretch, the year to date...

TeraWulf stock has delivered a very large 3 year gain, yet its current valuation checks do not flag it as a clear bargain. After a sharp run and recent pullback, investors are left weighing strong past returns against a weak overall value score. Over the past 3 years, TeraWulf has returned about 5.8x, which puts extra focus on whether today’s price still leaves much room for error. Recent attention around AI data center financing and sector deals may support growth expectations for TeraWulf,...

Heavy spending on AI by Big Tech is creating a clear split in market opinion. Investors are rewarding companies like Microsoft and Amazon that can point to real AI revenue, while punishing those with vague AI ambitions and weak free cash flow such as Alphabet and Meta. At the same time, consumer appetite for new tech and AI features from companies like Apple and Google remains strong. This article looks at 3 Consumer Technology Innovators that are exposed to this AI news cycle and may offer...

In late July 2026, DXC Technology issued earnings guidance pointing to an organic revenue decline for both the second quarter and full fiscal 2027, while also reshaping its leadership team and advancing an AI-focused transformation that includes a new President role and expanded AI innovation remit. Alongside this, DXC deepened its AI ambitions through new senior appointments and a partnership and investment with voice AI company ElevenLabs, aiming to embed advanced voice capabilities across...